Abstract: Compositions, devices and methods are described for preventing, reducing, controlling or delaying adhesion, adsorption, surface-mediated clot formation, or coagulation in a microfluidic device or chip. In one embodiment, blood (or other fluid with blood components) that contains anticoagulant is introduced into a microfluidic device comprising one or more additive channels containing one or more reagents that will re-activate the native coagulation cascade in the blood that makes contact with it “on-chip” before moving into the experimental region of the chip.

Abstract: Compositions, devices and methods are described for preventing, reducing, controlling or delaying adhesion, adsorption, surface-mediated clot formation, or coagulation in a microfluidic device or chip. In one embodiment, blood (or other fluid with blood components) that contains anticoagulant is introduced into a microfluidic device comprising one or more additive channels containing one or more reagents that will re-activate the native coagulation cascade in the blood that makes contact with it “on-chip” before moving into the experimental region of the chip.

Abstract: Compositions, devices and methods are described for preventing, reducing, controlling or delaying adhesion, adsorption, surface-mediated clot formation, or coagulation in a microfluidic device or chip. In one embodiment, blood (or other fluid with blood components) that contains anticoagulant is introduced into a microfluidic device comprising one or more additive channels containing one or more reagents that will re-activate the native coagulation cascade in the blood that makes contact with it “on-chip” before moving into the experimental region of the chip.

Abstract: Compositions, devices and methods are described for preventing, reducing, controlling or delaying adhesion, adsorption, surface-mediated clot formation, or coagulation in a microfluidic device or chip. In one embodiment, blood (or other fluid with blood components) that contains anticoagulant is introduced into a microfluidic device comprising one or more additive channels containing one or more reagents that will re-activate the native coagulation cascade in the blood that makes contact with it “on-chip” before moving into the experimental region of the chip.

Abstract: Compositions, devices and methods are described for preventing, reducing, controlling or delaying adhesion, adsorption, surface-mediated clot formation, or coagulation in a microfluidic device or chip. In one embodiment, blood (or other fluid with blood components) that contains anticoagulant is introduced into a microfluidic device comprising one or more additive channels containing one or more reagents that will re-activate the native coagulation cascade in the blood that makes contact with it “on-chip” before moving into the experimental region of the chip.

Abstract: An Internet of things (IoT) system includes a user device for receiving a user setting mode execution command, a sensor for acquiring surrounding environment information based on the user setting mode upon receiving the user setting mode execution command from the user device, and a server device for determining a composite hazard index of environmental conditions based on the acquired environment information and prestored hazard index data and determining that the environmental conditions are hazardous if the composite hazard index is less than a predetermined reference value.

Abstract: The invention relates to culturing motor neuron cells together with skeletal muscle cells in a fluidic device under conditions whereby the interaction of these cells mimic the structure and function of the neuromuscular junction (NMJ) providing a NMJ-on-chip. Good viability, formation of myo-fibers and function of skeletal muscle cells on fluidic chips allow for measurements of muscle cell contractions. Embodiments of motor neurons co-cultures with contractile myo-fibers are contemplated for use with modeling diseases affecting NMJ's, e.g. Amyotrophic lateral sclerosis (ALS).

Abstract: The present invention relates to an optically diffusing fiber probe, a method for manufacturing the same, and an application thereof. More specifically, the present invention relates to an optically diffusing fiber probe capable of emitting light in a plurality of directions and a method for manufacturing the same, hybrid optical medical equipment for both diagnosis and treatment of tubular human tissue, a catheter-based laser treatment device, and an electromagnetic energy application device for tubular tissue stricture, comprising the optically diffusing fiber probe.

Abstract: A cargo screen device for a vehicle may include a housing unit which has a screen drawing groove, and a screen unit which includes a screen member that may be wound in the housing unit, or deployed from the housing unit through the screen drawing groove, wherein the screen unit includes a wire member which may be made of a flexible material, and coupled to the screen member along a tip of the screen member.

Abstract: Provided is a manufacturing method of a lithium-titanium composite oxide doped with different metals, solid-phase mixing after adjusting a mixing ratio of two kinds of different metals and pulverizing the same, and spray drying the same to adjust contents of impurities, and a lithium-titanium composite oxide doped with different metals manufactured therefrom. By doping two kinds of different metals on the surface of the lithium-titanium composite oxide after adjusting the ratio of the two different metals to be a desirable ratio, the contents of rutile-type titanium dioxide, anatase-type titanium dioxide and Li2TiO3 which have been included as impurities are reduced, thereby manufacturing titanium dioxide having excellent capacity characteristics and structural characteristics, and a battery including the titanium dioxide having excellent battery characteristics of high initial charge and discharge efficiency and rate capability.

Abstract: A cargo screen device for a vehicle may include a housing unit which has a screen drawing groove, and a screen unit which includes a screen member that may be wound in the housing unit, or deployed from the housing unit through the screen drawing groove, wherein the screen unit includes a wire member which may be made of a flexible material, and coupled to the screen member along a tip of the screen member.

Abstract: The present invention relates to a lithium-manganese composite oxide in which the size of the face angle (vertical angle) of a primary particle is adjusted, and a method for preparing the same. The lithium-manganese composite oxide in which the size of the vertical angle of the primary particle is adjusted, and the method for preparing the same according to the present invention may gently adjust the size of the vertical angle of the polygon that constitutes a primary particle having a shape of a convex polyhedron in the lithium-manganese composite oxide, thus preventing the formation of convex-concave portions at the surface of an electrode plate in the process of forming the electrode plate by means of rolling during the manufacturing of a battery, thereby having an effect of improving characteristics of the battery.

Abstract: The present invention relates to a lithium manganese composite oxide and a method for preparing the same, and more particularly, to a lithium manganese composite oxide and a method for preparing same, in which a wet-milling process and a spray-drying process are applied, and the abundance ratio of Mn3+ ions to Mn4+ ions at the surface of the composite oxide is adjusted by controlling an oxidizing atmosphere during heat treatment.